CN101652346B - 吲哚衍生物、其制备方法以及其用途，尤其是作为抗菌剂的用途 - Google Patents

吲哚衍生物、其制备方法以及其用途，尤其是作为抗菌剂的用途 Download PDF

Info

Publication number
CN101652346B
CN101652346B CN2008800097669A CN200880009766A CN101652346B CN 101652346 B CN101652346 B CN 101652346B CN 2008800097669 A CN2008800097669 A CN 2008800097669A CN 200880009766 A CN200880009766 A CN 200880009766A CN 101652346 B CN101652346 B CN 101652346B
Authority
CN
China
Prior art keywords
compound
formula
hydrogen atom
group
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008800097669A
Other languages
English (en)
Chinese (zh)
Other versions
CN101652346A (zh
Inventor
J-N·M·L·丹尼斯
X·J·G·M·古因查德
N·J·莫雷亚氏拉丰
L·尼维勒
Y·沃里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Joseph fourier university
Original Assignee
Joseph fourier university
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph fourier university filed Critical Joseph fourier university
Publication of CN101652346A publication Critical patent/CN101652346A/zh
Application granted granted Critical
Publication of CN101652346B publication Critical patent/CN101652346B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CN2008800097669A 2007-02-01 2008-01-31 吲哚衍生物、其制备方法以及其用途，尤其是作为抗菌剂的用途 Expired - Fee Related CN101652346B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0700717 2007-02-01
FR0700717A FR2912133B1 (fr) 2007-02-01 2007-02-01 Nouveaux derives indoliques,leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens
PCT/FR2008/000118 WO2008110690A2 (fr) 2007-02-01 2008-01-31 Nouveaux derives indoliques, leurs procedes de preparation et leurs utilisations notamment en tant qu'antibacteriens

Publications (2)

Publication Number Publication Date
CN101652346A CN101652346A (zh) 2010-02-17
CN101652346B true CN101652346B (zh) 2013-10-30

Family

ID=38476052

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008800097669A Expired - Fee Related CN101652346B (zh) 2007-02-01 2008-01-31 吲哚衍生物、其制备方法以及其用途，尤其是作为抗菌剂的用途

Country Status (9)

Country Link
US (1) US8343964B2 (https=)
EP (1) EP2121601B8 (https=)
JP (1) JP5368317B2 (https=)
CN (1) CN101652346B (https=)
AU (1) AU2008224776B2 (https=)
CA (1) CA2677146C (https=)
FR (1) FR2912133B1 (https=)
RU (1) RU2464261C2 (https=)
WO (1) WO2008110690A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011060976A1 (en) 2009-11-20 2011-05-26 Universite De Liege Tryptamine-derived compounds as antibacterial agents
FR2969150B1 (fr) * 2010-12-20 2013-07-26 Centre Nat Rech Scient Nouvelles molecules indoliques demontrant des activites antibacteriennes dans une variete de bacteries a gram-negatif et positif dont des bacteries multidrogues-resistantes
ES2464598T3 (es) 2011-07-22 2014-06-03 Université Joseph Fourier Nuevos derivados bis-indólicos, procedimiento para su preparación, y sus utilizaciones como fármaco
EP2548865B1 (en) 2011-07-22 2014-03-05 Université Joseph Fourier Novel bis-indolic derivatives, their uses in particular as antibacterials
EP2639220A1 (en) * 2012-03-15 2013-09-18 Omnia Molecular, S. L. Indole derivatives and their use as antibiotics
CN103664733B (zh) * 2013-12-10 2016-04-20 邯郸惠达化工有限公司 一种吲哚啉的制备方法
CN105669519B (zh) * 2016-01-04 2018-01-05 北方民族大学 吲哚类化合物、制备方法及其作为抗耐药菌药物的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
CN1784380A (zh) * 2003-05-08 2006-06-07 诺瓦蒂什股份公司 新的放线酰胺素生物电子等排体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328902A (en) * 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
CA2444597A1 (en) * 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
DE602004016831D1 (de) * 2003-03-17 2008-11-13 Affinium Pharm Inc Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
CN1784380A (zh) * 2003-05-08 2006-06-07 诺瓦蒂什股份公司 新的放线酰胺素生物电子等排体

Also Published As

Publication number Publication date
FR2912133B1 (fr) 2009-04-24
EP2121601A2 (fr) 2009-11-25
RU2464261C2 (ru) 2012-10-20
RU2009132657A (ru) 2011-03-10
EP2121601B1 (fr) 2016-06-15
AU2008224776A1 (en) 2008-09-18
US20100144726A1 (en) 2010-06-10
FR2912133A1 (fr) 2008-08-08
EP2121601B8 (fr) 2016-12-07
CA2677146C (fr) 2016-11-15
CA2677146A1 (fr) 2008-09-18
WO2008110690A3 (fr) 2009-03-19
US8343964B2 (en) 2013-01-01
CN101652346A (zh) 2010-02-17
AU2008224776B2 (en) 2012-09-06
JP5368317B2 (ja) 2013-12-18
JP2010517983A (ja) 2010-05-27
WO2008110690A2 (fr) 2008-09-18

Similar Documents

Publication Publication Date Title
CN101652346B (zh) 吲哚衍生物、其制备方法以及其用途，尤其是作为抗菌剂的用途
Humphrey et al. Practical methodologies for the synthesis of indoles
US8822702B2 (en) Synthesis of amines and intermediates for the synthesis thereof
CA2293418A1 (en) Quinoline-indole antimicrobial agents, uses and compositions related thereto
PT93947B (pt) Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
KR19990072124A (ko) 고나도트로핀 방출 호르몬의 길항제
HUP0402317A2 (hu) Szulfonamidszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ZA200500021B (en) 1-(Aminoalkyl)-3-sylfonnylindole and -indazole derivatives as 5-hydroxytryptamine-5 ligands
JP2004529887A (ja) 腫瘍治療のためのプロドラッグとしてのピロロ−インドールおよびピロロ−キノリン誘導体
EP2548865B1 (en) Novel bis-indolic derivatives, their uses in particular as antibacterials
AU2017300841B2 (en) Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof
TW492958B (en) Compounds having NMDA (n-methyl-d-aspartate)-antagonizing activity, preparation process and pharmaceutical compositions thereof
JP2004522781A (ja) 腫瘍処置のためのプロドラッグとしてのインドリンおよびテトラヒドロ−キノリン
CN107922334A (zh) 多环吲哚啉和假吲哚化合物
Li Indoles, oxindoles, and azaindoles
EP2548864B1 (en) Novel bis-indolic derivatives, a process for preparing the same and their uses as a drug
Thaker et al. Synthesis, Biological Evolution and ADME Studies of Bis-Indole Analogues
CN1878767B (zh) 唑基激酶抑制剂
KR20050024310A (ko) 5-하이드록시트립타민-6-리간드로서의1-(아미노알킬)-3-설포닐인돌 및 -인다졸 유도체
Lin et al. Novel One-Pot Access to 3, 3-bis (3-hydroxy-5-substituted-1H-pyrazol-4-yl) indolin-2-ones.
Dacko The synthesis of tryptophan derivatives, 2-and/or 3-substituted indoles, progress toward dilemmaones AC, and synthetic studies towards fistulosin via palladium-catalyzed reductive N-heteroannulation
BR102014029028A2 (pt) novos derivados 2-(1h-indol-3-il-metileno) -n-fenil-hidrazina-carbotioamidas antitumorais
Phutdhawong et al. Synthesis and Evaluation of 3-((2-(1H-Indol-3-Yl) Ethyl) Amino)-3-Hydroxyoxindoles and Derivatives for Antibacterial Activity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131030

Termination date: 20190131

CF01 Termination of patent right due to non-payment of annual fee